ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650931; 2) Community: the network communities that were significantly associated with the response to NSC 650931; 3) Molecule: the relationships between components within communities and NSC 650931; 4) MDR: the compounds that were significantly associated with the NSC 650931.

NSC Compound Enrichment Correlation
NSC 670284 Null 0.00423163567577551 0.29810204
NSC 673456 Null 0.00423163567577551 0.36403182
NSC 708390 Null 0.00423163567577551 0.4359208
NSC 708423 Null 0.00423163567577551 0.5060218
NSC 720447 Null 0.00423163567577551 -0.1580121
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00423163567577551 0.049613866
NSC 105132 Deoxycamptothecin 0.00550789647802199 0.76917922
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.00550789647802199 0.5037575
NSC 632573 Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) 0.00550789647802199 0.58546846
NSC 641241 2-Naphthalenebutanamide, alpha-,gamma-dioxo-beta-(3-oxo -2-benzoisofuran-1-yl)-N-[3-(trifluoromethyl)phenyl]- 0.00550789647802199 0.52391277
Total:89  Current:16    [First] [Prev] [Next] [Last]